NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 46 filers reported holding NEOS THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $983,000 | -29.1% | 149,343 | 0.0% | 0.34% | -39.5% |
Q2 2016 | $1,386,000 | -14.0% | 149,343 | 0.0% | 0.55% | -17.2% |
Q1 2016 | $1,611,000 | -24.7% | 149,343 | 0.0% | 0.67% | +11.1% |
Q4 2015 | $2,139,000 | -48.9% | 149,343 | -25.1% | 0.60% | -24.8% |
Q3 2015 | $4,188,000 | – | 199,343 | – | 0.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 666,729 | $14,008,000 | 9.60% |
DSC Advisors, L.P. | 907,358 | $17,157,000 | 8.33% |
DAFNA Capital Management LLC | 63,400 | $1,332,000 | 1.32% |
WALL STREET ASSOCIATES | 199,343 | $4,188,000 | 0.80% |
Perceptive Advisors | 742,132 | $15,592,000 | 0.62% |
EMERALD MUTUAL FUND ADVISERS TRUST | 331,142 | $6,957,000 | 0.46% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 458,332 | $9,630,000 | 0.37% |
EMERALD ADVISERS, LLC | 321,313 | $6,751,000 | 0.35% |
Tourbillon Capital Partners, L.P. | 611,686 | $12,852,000 | 0.34% |
DSC Advisors, L.P. | 31,240 | $656,000 | 0.32% |